EPO and myelodysplastic syndrome: Previous studies have demonstrated that GDF11 has a critical role in normal erythropoiesis as well as the pathology of β-thalassemia, myelodysplastic syndrome (MDS), and erythropoietin-resistant anemia in hemodialysis (HD) patients [20, 66–68].